Millennium Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.45M | Sell |
13,775
-96,618
| -88% | -$24M | ﹤0.01% | 3339 |
|
|
2025
Q4 | $30.4M | Sell |
110,393
-202,593
| -65% | -$55.4M | 0.01% | 1180 |
|
|
2025
Q3 | $82.1M | Sell |
312,986
-152,601
| -33% | -$37.1M | 0.04% | 543 |
|
|
2025
Q2 | $102M | Buy |
465,587
+161,184
| +53% | +$34.5M | 0.05% | 382 |
|
|
2025
Q1 | $68.1M | Buy |
304,403
+84,786
| +39% | +$23.4M | 0.04% | 567 |
|
|
2024
Q4 | $71.9M | Buy |
+219,617
| New | +$69.1M | 0.04% | 565 |
|
|
2024
Q3 | – | Sell |
-393,857
| Closed | -$121M | – | 6526 |
|
|
2024
Q2 | $130M | Sell |
393,857
-122,769
| -24% | -$43.4M | 0.06% | 329 |
|
|
2024
Q1 | $204M | Buy |
516,626
+490,308
| +1,863% | +$181M | 0.09% | 195 |
|
|
2023
Q4 | $9.27M | Sell |
26,318
-4,998
| -16% | -$1.77M | ﹤0.01% | 2260 |
|
|
2023
Q3 | $11.8M | Sell |
31,316
-258,500
| -89% | -$100M | 0.01% | 1899 |
|
|
2023
Q2 | $111M | Buy |
289,816
+27,685
| +11% | +$9.89M | 0.05% | 319 |
|
|
2023
Q1 | $90.8M | Buy |
262,131
+172,883
| +194% | +$50.5M | 0.05% | 380 |
|
|
2022
Q4 | $21M | Sell |
89,248
-63,978
| -42% | -$15.2M | 0.01% | 1402 |
|
|
2022
Q3 | $37.7M | Buy |
153,226
+135,312
| +755% | +$41.2M | 0.02% | 857 |
|
|
2022
Q2 | $5.42M | Sell |
17,914
-18,474
| -51% | -$6.01M | ﹤0.01% | 2716 |
|
|
2022
Q1 | $14.9M | Buy |
36,388
+824
| +2% | +$323K | 0.01% | 1689 |
|
|
2021
Q4 | $16.7M | Buy |
35,564
+21,469
| +152% | +$9.24M | 0.01% | 1621 |
|
|
2021
Q3 | $5.98M | Sell |
14,095
-7,062
| -33% | -$2.98M | ﹤0.01% | 2657 |
|
|
2021
Q2 | $7.6M | Sell |
21,157
-111,244
| -84% | -$36.8M | ﹤0.01% | 2235 |
|
|
2021
Q1 | $37.3M | Sell |
132,401
-72,388
| -35% | -$20.7M | 0.03% | 656 |
|
|
2020
Q4 | $58M | Buy |
204,789
+187,008
| +1,052% | +$52.5M | 0.04% | 386 |
|
|
2020
Q3 | $4.89K | Sell |
17,781
-145,875
| -89% | -$38.6M | 0.01% | 1858 |
|
|
2020
Q2 | $37.2M | Sell |
163,656
-5,765
| -3% | -$1.13M | 0.05% | 421 |
|
|
2020
Q1 | $25.8M | Sell |
169,421
-279,048
| -62% | -$43M | 0.06% | 343 |
|
|
2019
Q4 | $67.4M | Sell |
448,469
-224,529
| -33% | -$32.7M | 0.08% | 247 |
|
|
2019
Q3 | $95.4M | Buy |
672,998
+521,158
| +343% | +$71.8M | 0.15% | 121 |
|
|
2019
Q2 | $19M | Sell |
151,840
-200,176
| -57% | -$23.6M | 0.03% | 823 |
|
|
2019
Q1 | $38.8M | Buy |
352,016
+200,268
| +132% | +$20.8M | 0.06% | 440 |
|
|
2018
Q4 | $14.9M | Buy |
151,748
+93,221
| +159% | +$10.1M | 0.02% | 871 |
|
|
2018
Q3 | $7.23M | Buy |
58,527
+55,786
| +2,035% | +$6.26M | 0.01% | 1539 |
|
|
2018
Q2 | $272K | Sell |
2,741
-191,952
| -99% | -$17.7M | ﹤0.01% | 3435 |
|
|
2018
Q1 | $17.2M | Buy |
194,693
+152,508
| +362% | +$14.3M | 0.02% | 968 |
|
|
2017
Q4 | $4.16M | Buy |
42,185
+35,339
| +516% | +$3.46M | 0.01% | 1833 |
|
|
2017
Q3 | $659K | Sell |
6,846
-723,479
| -99% | -$65.5M | ﹤0.01% | 2716 |
|
|
2017
Q2 | $69M | Sell |
730,325
-316,560
| -30% | -$29.1M | 0.12% | 206 |
|
|
2017
Q1 | $85.4M | Sell |
1,046,885
-119,855
| -10% | -$10M | 0.16% | 164 |
|
|
2016
Q4 | $99M | Buy |
1,166,740
+1,061,438
| +1,008% | +$83.5M | 0.21% | 91 |
|
|
2016
Q3 | $7.84M | Sell |
105,302
-15,305
| -13% | -$1.22M | 0.01% | 1059 |
|
|
2016
Q2 | $9.15M | Buy |
+120,607
| New | +$8.78M | 0.02% | 902 |
|
|
2016
Q1 | – | Sell |
-64,551
| Closed | -$3.89M | – | 3711 |
|
|
2015
Q4 | $3.89M | Buy |
+64,551
| New | +$3.88M | 0.01% | 1522 |
|
|
2015
Q1 | – | Sell |
-15,582
| Closed | -$830K | – | 4179 |
|
|
2014
Q4 | $830K | Sell |
15,582
-12,665
| -45% | -$633K | ﹤0.01% | 2626 |
|
|
2014
Q3 | $1.26M | Sell |
28,247
-136,122
| -83% | -$5.78M | ﹤0.01% | 2154 |
|
|
2014
Q2 | $6.93M | Sell |
164,369
-24,059
| -13% | -$1.03M | 0.02% | 1011 |
|
|
2014
Q1 | $8.3M | Buy |
188,428
+183,366
| +3,622% | +$8.63M | 0.02% | 911 |
|
|
2013
Q4 | $248K | Buy |
+5,062
| New | +$237K | ﹤0.01% | 3164 |
|
Other funds holding WST
VCM
VPM
GIM
Millennium Management's WST Position: Q1 2026 in Review
Millennium Management reduced its West Pharmaceutical (WST) stake by 88% in Q1 2026, selling an estimated $24M and leaving 13,775 shares worth $3.45M. The position accounts for ﹤0.01% of the portfolio, ranked #3339.
Millennium Management first reported a position in WST in Q4 2013 and has held it in 45 quarters since. The position peaked at $204M in Q1 2024. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.
- Millennium Management held 13,775 shares of West Pharmaceutical worth $3.45M as of Q1 2026.
- Millennium Management sold 96,618 West Pharmaceutical shares in Q1 2026, an estimated $24M.
- West Pharmaceutical made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3339 holding.
- Millennium Management first reported a position in West Pharmaceutical in Q4 2013 and has held it in 45 quarters since.
- Millennium Management's West Pharmaceutical position peaked at $204M in Q1 2024.
- 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.